Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Isabel Barragán

11PUBLICATIONS
30CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

Sort by Publication Date:
|Mar 31, 2026
Integrating tumor and immune cell transcriptomics to predict immune checkpoint inhibitor primary resistance in metastatic melanoma.

Juan Luis Onieva, Elisabeth Pérez-Ruiz, Ville Vilkki

|Jan 16, 2026
Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC.

Juan Luis Onieva, Elisabeth Pérez-Ruiz, Laura Cristina Figueroa-Ortiz

|Apr 27, 2024
Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer.

Juan Zafra, Juan Luis Onieva, Javier Oliver

|Jul 14, 2023
Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade.

Javier Oliver, Juan Luis Onieva, María Garrido-Barros

|Feb 10, 2023
Preclinical models in head and neck squamous cell carcinoma.

Patricia Chaves, María Garrido, Javier Oliver

|Oct 27, 2022
Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma.

Javier Oliver, Juan Luis Onieva, Maria Garrido-Barros

Pageof 2

Frequent Collaborators

8 joint publications

Elisabeth Pérez-Ruiz

5 joint publications

Juan Luis Onieva

5 joint publications

Javier Oliver

3 joint publications

Miguel-Angel Berciano-Guerrero

2 joint publications

Manuel Cobo-Dols

2 joint publications

Juan Zafra Martín

2 joint publications

Beatriz Martínez-Gálvez

2 joint publications

José Carlos Benítez

2 joint publications

Antonio Rueda-Dominguez

1 joint publications

R Jiménez-Guerrero

Frequent Collaborators

8 joint publications

Elisabeth Pérez-Ruiz

5 joint publications

Juan Luis Onieva

5 joint publications

Javier Oliver

3 joint publications

Miguel-Angel Berciano-Guerrero

Top Related Videos

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on : Feb 25, 2020

7.7K
Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker

Published on : Sep 15, 2023

2.2K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.9K
See more related videos

Top Related Videos

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on : Feb 25, 2020

7.7K
Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker

Published on : Sep 15, 2023

2.2K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.9K
See more related videos